The replacement of miR-145 also induced the concomitant downregulation of other oncogenes related to BC, including cyclin D1, FGFR3∗, Fascin∗, c-Myc∗, and PTBP1∗ (∗direct targets of miR-145; Figure 1H). Here, FSCN1 is linked to breast cancer.